China · Delayed Price · Currency is CNY Evopoint Biosciences Statistics
Total Valuation
SHA:688837 has a market cap or net worth of CNY 21.51 billion. The enterprise value is 21.82 billion.
| Market Cap | 21.51B |
| Enterprise Value | 21.82B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688837 has 435.49 million shares outstanding. The number of shares has increased by 8.25% in one year.
| Current Share Class | 435.49M |
| Shares Outstanding | 435.49M |
| Shares Change (YoY) | +8.25% |
| Shares Change (QoQ) | -0.95% |
| Owned by Insiders (%) | 5.39% |
| Owned by Institutions (%) | 12.47% |
| Float | 111.80M |
Valuation Ratios
The trailing PE ratio is 44.71.
| PE Ratio | 44.71 |
| Forward PE | n/a |
| PS Ratio | 19.36 |
| PB Ratio | 40.17 |
| P/TBV Ratio | 40.80 |
| P/FCF Ratio | 101.61 |
| P/OCF Ratio | 79.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 43.79, with an EV/FCF ratio of 103.08.
| EV / Earnings | 53.42 |
| EV / Sales | 19.64 |
| EV / EBITDA | 43.79 |
| EV / EBIT | 47.64 |
| EV / FCF | 103.08 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 2.42.
| Current Ratio | 2.00 |
| Quick Ratio | 1.80 |
| Debt / Equity | 2.42 |
| Debt / EBITDA | 2.60 |
| Debt / FCF | 6.11 |
| Interest Coverage | 19.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 42.65% |
| Return on Capital Employed (ROCE) | 32.01% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.07M |
| Profits Per Employee | 1.13M |
| Employee Count | 362 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHA:688837 has paid 109.86 million in taxes.
| Income Tax | 109.86M |
| Effective Tax Rate | 21.19% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 24,243,745 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688837 had revenue of CNY 1.11 billion and earned 408.51 million in profits. Earnings per share was 1.11.
| Revenue | 1.11B |
| Gross Profit | 1.11B |
| Operating Income | 458.11M |
| Pretax Income | 518.37M |
| Net Income | 408.51M |
| EBITDA | 490.39M |
| EBIT | 458.11M |
| Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 983.36 million in cash and 1.29 billion in debt, with a net cash position of -310.83 million or -0.71 per share.
| Cash & Cash Equivalents | 983.36M |
| Total Debt | 1.29B |
| Net Cash | -310.83M |
| Net Cash Per Share | -0.71 |
| Equity (Book Value) | 535.59M |
| Book Value Per Share | 1.44 |
| Working Capital | 545.43M |
Cash Flow
In the last 12 months, operating cash flow was 270.32 million and capital expenditures -58.59 million, giving a free cash flow of 211.72 million.
| Operating Cash Flow | 270.32M |
| Capital Expenditures | -58.59M |
| Depreciation & Amortization | 32.28M |
| Net Borrowing | 457.01M |
| Free Cash Flow | 211.72M |
| FCF Per Share | 0.49 |
Margins
Gross margin is 100.00%, with operating and profit margins of 41.23% and 36.77%.
| Gross Margin | 100.00% |
| Operating Margin | 41.23% |
| Pretax Margin | 46.66% |
| Profit Margin | 36.77% |
| EBITDA Margin | 44.14% |
| EBIT Margin | 41.23% |
| FCF Margin | 19.06% |
Dividends & Yields
SHA:688837 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.62% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.25% |
| Shareholder Yield | -8.25% |
| Earnings Yield | 1.90% |
| FCF Yield | 0.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |